Skip to main content
OpenTrials
Completed

NCT Number: NCT02903693

Cervical Cancer in French Guiana: Screening Between 2006-2011

Given that cervical cancer is the second most frequent cancer among women in french guiana the aim of the study was to determine the screening rate among women living in French Guiana. Cervical smears are read in 2 laboratories which allowed us to compute screening rates per 100 women-years. overall the screening activity was 23.5-25.8 smears per 100 women-years. between 2006 and 2011 54% of women were screened. These baseline figures will allow to evaluate present efforts to increase the screening rate for this frequent cancer in French Guiana.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women screened

Exclusion criteria

-

Treatment and study plan

cross sectional

Other

Primary outcomes

  1. cervical cancer screening

    Time frame: 1 year (screening that year)

    Cytological examination screens for neoplasic lesion according to the Bethsda 2001, results are assessed on a yearly basis to obtain annual screening rates relative to the female population.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Cayenne

Other

Registry information

Official study title

Cervical Cancer in French Guiana: Screening Between 2006-2011. Description of the Population With Invasive Cervical Cancer Between 2003-2008

Acronym: DepCol

Important dates

Study start
2012
Primary completion
2012
Study completion
2013
First posted
Sep 16, 2016
Registry last updated
Sep 16, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.